Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto’s Thyroiditis and Its Treatment
International Journal of Molecular Sciences · 26.04.2024 · 25 (9) · 4703
DOI: 10.3390/ijms25094703 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.04.2024. Verfasst von Ewa Tywanek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Internal Medicine in Nursing, Medical University of Lublin, Witold Chodźki Street 7, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Hashimoto Disease, Biomarkers, Thyroid Gland, Autoimmunity. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoimmune thyroid disease (AITD) is the most common organic specific illness of the thyroid gland. It may manifest as the overproduction or the decline of thyroxine and triiodothyronine. Hyperthyroidism develops due to the overproduction of hormones as an answer to the presence of stimulatory antibodies against the TSH receptor. Hashimoto’s thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid. Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism. Pathophysiology of AITD is extremely complicated and still not fully understood, with genetic, environmental and epigenetic factors involved in its development. Due to increasing incidence and social awareness of this pathology, there is an urgent need to expand the background concerning AITD. A growing body of evidence suggests possible ways of treatment apart from traditional approaches. Simultaneously, the role of potential new biomarkers in the diagnosis and monitoring of AITD has been highlighted recently, too. Therefore, we decided to review therapeutic trends in the course of AITD based on its pathophysiological mechanisms, mainly focusing on HT. Another aim was to summarize the state of knowledge regarding the role of new biomarkers in this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Internal Medicine in Nursing, Medical University of Lublin, Witold Chodźki Street 7, 20-093 Lublin, Poland.
- Doctoral School, Medical University of Lublin, 20-093 Lublin, Poland.
- Endocrinology Department with Nuclear Medicine Department, Center of Oncology of the Lublin Region St. Jana z Dukli, Kazimierz Jaczewski Street 7, 20-090 Lublin, Poland.
- Department of Gastroenterology, Medical University of Lublin, Poland, Jaczewski Street 8, 20-954 Lublin, Poland.
ORCID-Profile: Ewa Tywanek, Agata Michalak
Zitieren
APA
Tywanek, E., Michalak, A., Świrska, J., & Zwolak, A. (2024). Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto’s Thyroiditis and Its Treatment. International Journal of Molecular Sciences, 25(9), 4703. https://doi.org/10.3390/ijms25094703
Vancouver
Tywanek E, Michalak A, Świrska J, Zwolak A. Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto’s Thyroiditis and Its Treatment. International Journal of Molecular Sciences. 2024;25(9):4703. doi:10.3390/ijms25094703
BibTeX
@article{Tywanek2024,
author = {Tywanek, Ewa and Michalak, Agata and Świrska, Joanna and Zwolak, Agnieszka},
title = {Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto’s Thyroiditis and Its Treatment},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {9},
pages = {4703},
doi = {10.3390/ijms25094703}
}
EUVIMED